The proto-oncoproteins ETS1 and growth factor independent-1 (GFI1) are implicated in cell growth and differentiation in various types of cells, and their deregulated expression is involved in malignant transformation. Here, we report that ETS1 and GFI1 interact and affect gene expression through their cross-talk. Co-immunoprecipitation analyses and glutathione-S-transferase pull-down assays revealed that ETS1 bound directly to GFI1 via its Ets domain, and GFI1 bound to ETS1 via its zincfinger domain. Luciferase (Luc) assays using artificial reporters showed that GFI1 repressed ETS1-mediated transcriptional activation and ETS1 repressed GFI1-mediated transcriptional activation, in a dose-dependent manner. However, in the Bax promoter where the Ets-and Gfi-binding sites (EBS and GBS) are adjacent, ETS1 and GFI1 cooperatively reduced activation. Site-directed mutagenesis on the EBS and GBS of the Bax promoter showed that both binding sites were necessary for full repression. Chromatin immunoprecipitation analyses confirmed that an ETS1-GFI1 complex formed on the Bax promoter even when either EBS or GBS was mutated. Introduction of small interfering RNA against ETS1 and/ or GFI1 enhanced endogenous Bax gene expression. Our results suggest that the interaction between ETS1 and GFI1 facilitates their binding to specific sites on the Bax promoter and represses Bax expression in vivo.
Introduction
Growth and differentiation of hematopoietic cells are regulated by a combination of ubiquitous and tissuespecific transcription factors responding to stimuli from several cytokines (Tenen et al., 1997; Graf, 2002) . Some of the Ets family transcription factors are expressed in a hematopoietic cell-restricted manner to control the expression of several hematopoietic cell-specific genes, and are also involved in leukemogenesis (Shivdasani and Orkin, 1996; Oikawa et al., 2005) . This family shares the Ets domain, a DNA-binding domain consisting of 85 evolutionally conserved amino acids, to bind GGAA/T core motifs in the promoters or enhancers of their target genes (Graves and Peterson, 1998; Sharrocks, 2001; Oikawa and Yamada, 2003) .
ETS1 is a member of the Ets family of transcription factors. It was originally identified as the mammalian homolog of the v-ets oncogene of the avian transforming retrovirus E26, which induces both erythroblastic and myeloblastic leukemias in chickens (Leprince et al., 1983) . High expression levels of ETS1 are restricted to lymphoid tissues in adult tissues. ETS1 controls the expression of several T-cell-specific genes including that of the T-cell receptor (TCR)a and b genes (Giese et al., 1995; Dittmer, 2003) . ETS1-deficient T cells were highly susceptible to cell death in vitro (Muthusamy et al., 1995) , suggesting that ETS1 has a functional role in resistance to apoptosis in T cells, as well as in T-cell differentiation.
Growth factor independent-1 (GFI1), a member of the Gfi-1 family of transcription factors, also plays important roles in normal hematopoiesis and leukemogenesis (Duan and Horwitz, 2003a, b) . GFI1 contains a repression domain called the SNAG domain at the N-terminus, and a DNA-binding domain consisting of six zinc (Zn)-finger domains at the C-terminus (Zweidler-Mckay et al., 1996) . GFI1 was first identified as a common integration site of Moloney murine leukemia virus in rat T-cell lymphoma cell lines selected for interleukin-2-independent growth after infection with the virus (Gilks et al., 1993) . Jurkat T cells transfected with a GFI1 expression vector showed accelerated cell proliferation and decreased cell death (Karsunky et al., 2002) . GFI1-deficient mice are severely neutropenic with effects on the CD4/CD8 lineage commitment in the thymus (Karsunky et al., 2002; Yu¨cel et al., 2003) , demonstrating that GFI1 is also involved in the differentiation of myeloid precursors into granulocytes or monocytes (Hock et al., 2003) , as well as in T-cell differentiation, growth and apoptosis.
As ETS1 and GFI1 are co-expressed in T cells, and both are implicated in apoptotic cell death, physical and functional interactions between these factors were investigated in this study.
Results

Physical interaction between ETS1 and GFI1
To verify the physical association between ETS1 and GFI1, we first performed co-immunoprecipitation assays. EL4 (500 mg) nuclear extract lysates were prepared and immunoprecipitated with an anti-GFI1 antibody. The proteins were detected by immunoblot analysis with an anti-human ETS1 antibody (Figure 1a) . Additionally, hemagglutinin (HA)-tag ETS1 and FLAG-tag GFI1 expression vectors were separately transfected into 293T cells and cell lysates were prepared. The cell lysates were mixed in equal amounts and then subjected to co-immunoprecipitation and immunoblot analyses. When the lysates were immunoprecipitated with anti-FLAG-tag antibody, immunoblot analysis using anti-HAtag antibody showed that HA-tag ETS1 co-precipitated with FLAG-tag GFI1 (Figure 1b) . Similarly, when the lysates from the cells transfected with the expression vectors of FLAG-tag ETS1 and HA-tag GFI1 were used, it was shown that HA-tag GFI1 was co-precipitated with an anti-FLAG-tag antibody (Figure 1c ), suggesting that ETS1 and GFI1 were physically associated in vivo.
Identification of the binding domains of ETS1 and GFI1
To investigate whether ETS1 interacts directly with GFI1, and to determine the region of ETS1 required for interaction with GFI1, we performed glutathione-Stransferase (GST) pull-down assay using the various deletion forms of GST-ETS1 fusion proteins shown in Figure 2a . FLAG-tag GFI1 was retained on the fulllength ETS1 (GST-ETS1 WT) and on ETS1 with the Ets domain alone (GST-ETS1 E) (Figure 2b ). On the other hand, it was not retained on either ETS1 having the pointed/sterile alpha motif (SAM) domain alone (GST-ETS1 P) or on the ETS1 lacking of E and P domains (GST-ETS1 C). These results indicate that ETS1 interacts with GFI1 directly through the Ets domain.
We performed further GST pull-down assays to determine the ETS1-binding site of GFI1 using deletion forms of FLAG-tag GFI1 expression vectors (Figure 2c ). GST-ETS1 WT retained the full-length GFI1 (FLAG-tag GFI1 WT) and GFI1 having the Znfinger domain intact (FLAG-tag GFI1 Zn), whereas it did not retain GFI1 with the Zn-finger domain deleted (FLAG-tag GFI1 DZn) (Figure 2d ). These data indicate that the Zn-finger domain of GFI1 is necessary for interaction with ETS1.
Mutual effects of ETS1 and GFI1 on their respective transcriptional activities
The above results raised the possibility that GFI1 could affect the transcriptional activity of ETS1, because it has been reported that GFI1 exhibiting a SNAG (Snail/ GFI1) functions as a transcriptional repressor (Grimes et al., 1996a, b; Tong et al., 1998) . To address this possibility, Luc reporter assays were performed using an artificial reporter construct consisting of a trimerized purine-rich (PU) box with the SV40 enhancer upstream of the thymidine kinase gene (pTK100-PU x3-Luc) promoter, as it was highly activated by ETS1 as well as by PU.1. The reporter plasmid with the PU.1-binding sites mutated (pTK100-PUmut x3-Luc) was also constructed (Figure 3a) . When an expression vector containing ETS1 and the pTK100-PU x3-Luc reporter was transfected into 293T cells, the reporter activity was increased about 55-fold. When GFI1 was co-expressed with ETS1, the activity was reduced 28-fold. Moreover, co-transfection of increasing amounts of the GFI1 expression vector resulted in reduction of the reporter activity in a dose-dependent manner (Figure 3b ). Expression of ETS1 showed no effect on the activity of pTK100-PUmut x3-Luc reporter. Expression of Lysates from the cells transfected with a HA-tag GFI1 or FLAGtag ETS1 expression vector were mixed in equal amounts and co-immunoprecipitated with anti-FLAG-tag antibody, and immunoblot analysis was performed with the anti-HA-tag antibody.
ETS1-GFI1 interaction in the repression of Bax gene expression Y Nakazawa et al GFI1 also showed no effects on the activities of pTK100-PU x3-Luc and pTK100-PUmut x3-Luc constructs ( Figure 3b ). These results suggest that GFI1 counteracts ETS1-mediated transcriptional activation through association with ETS1. Similarly, there is a possibility that ETS1 might affect the transcriptional activity of GFI1. Thus, we performed Luc reporter assays using artificial reporters with or without Gfi-binding sites upstream of the TK promoters, pTK81-Gfi x4-Luc and pTK81-Luc (Figure 4a ). When a GFI1 expression vector was transfected into 293T cells with pTK81-Gfi x4-Luc, reporter activity increased about sixfold ( Figure 4b , lane 2). When ETS1 was co-expressed with GFI1, the activity was reduced about fourfold. Moreover, co-transfection of increasing amounts of the ETS1 expression vector caused a reduction of the reporter activity in a dose-dependent manner (Figure 4b , lanes 4-6). Expression of GFI1 and/ or ETS1 showed no effect on the activity of pTK81-Luc reporter (Figure 4b, lanes 7-12) . These results suggest that ETS1 suppresses GFI1-dependent transcriptional activity via interaction with GFI1.
Effects of ETS1 and GFI1 on Bax promoter activity As already stated, ETS1 appears to participate in the inhibition of T-cell apoptosis (Bories et al., 1995; Muthusamy et al., 1995) , and overexpression of GFI1-induced T-cell proliferation and blocked apoptosis of GST pull-down assay was performed using GST-ETS1 deletion mutants and 293T-cell lysates transfected with a FLAG-tag GFI1 WT expression vector. Cell lysates were mixed and bound proteins were separated in Nu-PAGE (Invitrogen). Input was 10% of the amount of cell lysates. Immunoblot analysis was performed with anti-FLAG-tag antibody. (c) Schematic representation of expression vectors of GFI1 mutants. Numbers correspond to amino-acid positions in the GFI1 protein, and nuclear localization signal (NLS). (d) GST pull-down assay was performed using GST-ETS1 WT and 293T-cell lysate transfected with a FLAG-tag GFI1 WT, FLAG-tag GFI1 DZn or FLAG-tag GFI1 Zn expression vector. Cell lysates were mixed and bound proteins were separated in Nu-PAGE. Input was 10% of the amount of cell lysates.
Immunoblot analysis was performed with an anti-FLAG-tag antibody. ETS1-GFI1 interaction in the repression of Bax gene expression Y Nakazawa et al cells induced by cytokine deprivation (Duan and Horwitz, 2003b) . Therefore, we speculated that ETS1 and GFI1 might control apoptosis-related genes in T cells. We referred to the promoter sequences of apoptosis-related genes and consequently noticed that the sequence of the Bax promoter contains both Etsand Gfi-binding sites (EBS and GBS) that are adjacent. In order to unravel the influence of the interaction between ETS1 and GFI1 on the Bax promoter activity, we performed Luc reporter assays using a reporter plasmid composed of the Bax promoter sequences upstream to the Luc gene ( Figure 5a ). The reporter assays revealed that expression of either ETS1 or GFI1 reduced Bax promoter activity in a dose-dependent manner ( Figure 5b , lanes 1-4 and 5-8). Furthermore, expression of both ETS1 and GFI1 resulted in further reduction of the activity (Figure 5b , lanes 9-12). These results suggest that ETS1 and GFI1 cooperate to control Bax promoter activity.
Localization of the ETS1-GFI1 complex on Bax promoter locus
We next try to determine the biological significance of the complex formation of ETS1 with GFI1 on Bax promoter function. To this end, we used 293T cells transfected with ETS1 and/or GFI1 expression vectors for chromatin immunoprecipitation (ChIP) analysis. In ChIP analysis, chromatin immunoprecipitates were obtained with an anti-FLAG-tag antibody from lysates of 293T cells transfected with a FLAG-tag GFI1 These results, taken together with the results of Luc assays, support the notion that the GFI1-ETS1 complex colocalized directly on the Bax promoter to reduce its activity.
Effects of ETS1 and GFI1 on the activities of mutated Bax promoter sequences To examine which binding site, the EBS or the GBS, is more important for Bax promoter activity, we performed reporter assays using the mutated Bax promoter sequences placed upstream of the Luc gene. The Bax promoter mutated in the EBS region (Bax promoter mut EBS), in the GBS region (Bax promoter mut GBS) and in both EBS and GBS regions (Bax promoter mut E,GBS) were constructed from wild-type Bax promoter (Bax promoter WT) by site-directed mutagenesis (Figure 6a ). Expression of either Ets-1 or GFI1 showed reduction in the WT Bax promoter activity, whereas expression of both proteins together showed more reduced activity (Figure 6b, lanes 1-4) . Expression of GFI1 reduced the activity of Bax promoter mut EBS, whereas ETS1 did not (Figure 6b, lanes 5-8) . Similarly, expression of ETS1 reduced the activity of Bax promoter mut GBS, whereas expression of GFI1 did not (Figure 6b, lanes 9-12) . No changes in the activity of the Bax promoter mut E,GBS were observed with ETS1 and/or GFI1 expression (Figure 6b, lanes 13-16) . From these results, it is very likely that both EBS and GBS are indispensable for maximum repression of Bax gene expression, and that ETS1 and GFI1 act cooperatively on the promoter. To examine whether the GFI1-ETS1 complex binds these mutated Bax promoters, we carried out ChIP assay using lysates from 293T cells transfected with ETS1 and FLAG-tag GFI1 expression vectors, and the mutated promoters. Chromatin immunoprecipitates obtained with the anti-ETS1 and FLAG-tag antibodies from 293T cells transfected with the Bax promoter enriched for the chromatin including the DNA sequences of the Bax promoter (Figure 6c , and ETS1 and FLAG-tag GFI1 expression vectors (4 mg each). Proteins from the transfectants of 293T cells were immunoprecipitated using nonspecific IgG, or anti-ETS1 or FLAG-tag antibody. DNA extracted from the immunoprecipitated chromatin samples was amplified by PCR with Bax promoter-specific primers.
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Although the immunoprecipitates obtained with anti-FLAG-tag antibody from 293T cells transfected with the Bax promoter mut EBS-enriched DNA to levels comparable to those obtained with the WT Bax promoter, less enriched DNA was observed with an anti-ETS1 antibody ( Figure 6c, lane 2) . Similarly, the immunoprecipitates obtained with anti-ETS1 antibody from 293T cells transfected with Bax promoter mut GBS and the expression vectors enriched DNA to levels comparable to those obtained with WT Bax promoter, less enriched DNA was observed with anti-FLAG-tag antibody (Figure 6c, lane 3) . No immunoprecipitates were obtained with an anti-ETS1 antibody and/or anti-FLAG-tag antibody from 293T cells transfected with the Bax promoter mut E,GBS (Figure 6c, lane 4) . These data suggest that the GFI1-ETS1 complex associates with the Bax promoter even if there was only one binding site for either ETS1 or GFI1 on the promoter. These results also suggest that the GFI1-ETS1 complex might stably bind to the DNA sequence of the Bax promoter because of the adjacent location of their binding sites.
Increased Bax gene expression by knocking down endogenous ETS1 and GFI1 with RNAi RNA interference (RNAi) has rapidly emerged as an efficient procedure for knocking down gene expression in model systems (Sledz and Williams, 2005) . Therefore, we used this strategy to determine whether changes in expression levels of endogenous ETS1 and GFI1 had influence on endogenous Bax gene expression in 293T cells. 293T cells were transfected with human ETS1 small interfering RNA (siRNA) (Santa Cruz, Santa Cruz, CA, USA) and/or human GFI1 siRNA (Santa Cruz) or control green fluorescent protein (GFP) siRNA (Nippongene, Tokyo, Japan). Introduction of ETS1 siRNA and GFI1 siRNA specifically reduced endogenous expression of ETS1 and GFI1, respectively ( Figure 7 , lanes 1 and 2). In the 293T cells transfected with ETS1 siRNA and GFI1 siRNA simultaneously, constitutive expression of the endogenous Bax gene increased ( Figure 7 , lane 3). There was no effect on the expression of the ETS1, GFI1 and Bax genes in cells transfected with GFP siRNA (Figure 7 , lane 4). These results indicate that ETS1 and GFI1 cooperatively regulate Bax gene expression in vivo as well.
Discussion
In this study, we present experimental evidence for the physical and functional interactions between ETS1 and GFI1 transcription factors. The physical interaction between the two proteins was evident in immunoprecipitation assays, where ETS1 was co-immunoprecipitated with GFI1, and vice versa. GST pull-down assay using the respective deletion mutants revealed that their interacting sites were located within the Ets domain (aa 330-415) of ETS1 and in the Zn-finger domain (aa 254-423) of GFI1. The results also suggest that ETS1 and GFI1 interact directly. As the Ets domain and Zn-finger domain contain the DNA-binding domain of ETS1 and GFI1, respectively (Jonsen et al., 1996; Zweidler-Mckay et al., 1996) , interaction of these proteins might inhibit their DNAbinding activities. The ChIP assays, however, revealed that the DNA-binding activities of ETS1 and GFI1 were not abrogated by their interactions, suggesting that the regions required for DNA binding are different from the protein-interacting domains in the molecules. Spatially close but different DNA-binding domains and proteininteraction domains have also been reported in interactions between TCF and SRF (Hassler and Richmond, 2001 ), ETS1 and AML1 (Kim et al., 1999) and PU.1 and PU.1 interacting partner (PIP)/interferon regulatory factor-4 (Escalante et al., 2002) .
Luc assays showed that the interaction affected the transcriptional activities of these transcription factors. Using reporter constructs engineered to contain the respective binding sites, ETS1 was found to repress transcriptional activation by GFI1 and conversely GFI1 repressed transcriptional activation by ETS1, in a dosedependent manner. GFI1 has been reported to contain a 22 aa SNAG domain at the N-terminal region to repress transcription through interaction with histone deacetylases (HDACs) (McGhee et al., 2003) . Thus, GFI1 may recruit transcriptional corepressors to inhibit the activity of ETS1. On the other hand, we and others reported Enhanced endogenous Bax gene expression after transfection of siRNA against ETS1 and GFI1. Transfection with siRNA against human ETS1 and GFI1 specifically knocked down the endogenous expression of ETS1 and GFI1, respectively, in 293T cells. Expression of the endogenous Bax gene was enhanced slightly with ETS1 siRNA (lane 1) transfection and moderately with GFI1 siRNA (lane 2). The expression was mostly enhanced with transfection of both ETS1 siRNA and GFI1 siRNA (lane 3). The total amounts of siRNA were adjusted to GFP siRNA. GFP siRNA had no effects on expression of the ETS1, GFI1 and Bax genes (lane 4).
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Y Nakazawa et al previously that PU.1, another member of the ETS family, also forms a complex with mSin3A/HDAC1 and MeCP2 under certain conditions (Kihara-Negishi et al., 2001; Suzuki et al., 2003; Hwang et al., 2004) . Therefore, ETS1 might also be able to recruit transcriptional corepressors. ETS1 is preferentially expressed at high levels in T cells and appears to be required for survival and induction of T-cell growth, as ETS1 À/À Rag-2 À/À chimeric mice display a marked decrease in the number of mature T cells, and a severely deficient proliferation in response to several signals with increased rates of spontaneous T-cell apoptosis (Bories et al., 1995) . Furthermore, GFI1 is expressed in hematopoietic cells as well as in other organs, and overexpression of GFI1 inhibits apoptosis of T cells (Karsunky et al., 2002) , during which the protein and mRNA levels of the proapoptotic molecule Bax are downregulated (Grimes et al., 1996a, b) . By careful examination of the nucleotide sequences in the Bax promoter, we found that an EBS is located in tandem just adjacent to a GBS. Thus, it was speculated that both transcription factors might act cooperatively to repress Bax promoter activity. In the present study, we clearly showed that introduction of expression vectors for ETS1 or GFI1 reduced Bax promoter activity in 293T cells. Moreover, simultaneous expression of ETS1 and GFI1 showed more reduction in this activity, suggesting that interactions between these factors are responsible for cooperative repression of the Bax promoter activity. Transcription factor complex formation on the Bax promoter was confirmed by the results of ChIP assays. The results of Luc assays using Bax promoters mutated at the EBS and/or GBS regions further support the indications that both sites are necessary for maximum repression of the Bax promoter activity, as repression of the promoter activity was observed when either EBS or GBS was mutated, but not when the both sites were mutated. The results of ChIP assays using these mutated promoters showed that the GFI1-ETS1 complex was indeed located on the Bax promoter even when EBS or GBS was mutated. Furthermore, much of the complex bound more stably when the binding sites for both of the transcription factors were intact than when either of them was mutated, which appeared to correlate with the results of the Luc assay. Thus, the ETS1-GFI1 complex might associate via one transcription factor or the other bound to the EBS or GBS regions on the Bax promoter. These data clearly showed that ETS1 and GFI1 proteins bind to the specific sequences on the Bax promoter and reduce its activity cooperatively.
Experiments of introduction of siRNA against ETS1 and GFI1 in 293T cells revealed that these transcription factors are also important for expression of the endogenous Bax gene as well. It has been reported that GFI1 is highly expressed in small-cell lung cancer (Kazanjian et al., 2004) , and expression of ETS1 is related to the grade of malignancy of tumors (Davidson et al., 2003; Oikawa, 2004) . Cooperative repression of Bax promoter activity by ETS1 and GFI1 may be responsible for inhibition of apoptosis in lung cancer as well as is observed in T-cell lymphomas.
In this study, we focused our experiments only on the effect of cooperation of ETS1 and GFI1 on apoptosis. Considering that ETS1 is implicated in the expression of several T-cell-specific genes including the CD4 and TCRa/b genes (Salmon et al., 1993; Helle et al., 1997) , and that the overexpression of GFI1 in transgenic mice induces T-cell lymphoma and a block in T-cell differentiation (Schmidt et al., 1998; Yu¨cel et al., 2003) . ETS1 and GFI1 interaction might have antagonistic effects on the expression of some T-cell-specific genes and inhibit T-cell differentiation. Moreover, as it has been reported that GFI1 is recruited by several growth-related target genes like c-myc, Ets-2 and p21 WAF1 genes (Duan and Horwitz, 2003a) , and that GFI1 enhances STAT3 signaling (Ro¨del et al., 2000) , interaction of ETS1 and GFI1 might affect cell growth as well. Further studies are necessary to answer these points and their implications on hematopoiesis and oncogenesis.
Materials and methods
Cell culture
All the cells used this study were maintained under the standard conditions of 5% CO 2 at 371C in Dulbecco's modified Eagle minimum essential medium (MEM), supplemented with L-glutamine (Nissui, Japan) and 10% fetal calf serum (BioWest, Miami, FL, USA).
Construction of vectors
The GST-fusion protein expression vectors were constructed by subcloning of the human ETS1 gene in frame into the pGEX-4T vector (GE healthcare, Piscataway, NJ, USA). The cDNA fragments of ETS1 deletion mutants were obtained by PCR, using the combinations of the following primers; forward-1 (from 987-1006 nt); 5 0 -CCCAAGCTTACAGG CAGTGGACCAATCAG-3 0 (HindIII site is underlined), forward-2 (from 401 to 412 nt); 5 0 -CCCAAGCTTAAGAG GATGTGA-3 0 (HindIII site is underlined), reverse-1 (from 1305 to 1324 nt); 5 0 -CCGCTCGAGTCACTCGTCGGCAT CTGGCTT-3 0 (Xho1 site is underlined), and reverse -2 (from 984 to 995 nt); 5 0 -CGGGATCCACTGCCTGTGTA-3 0 (BamH1 site is underlined).
GST-ETS1 E (E stands for the Ets domain) was obtained by using forward-1 and reverse-1 primers, and GST-ETS1 C (C stands for the central region with deletion of the Ets domain and the pointed/SAM domain) using forward-2 and reverse-2 primers. Deletion mutants were also subcloned into the pGEX-4T vector. GST-ETS1 P (P stands for the pointed domain) was obtained by cutting off a C-terminal fragment with BamH1 from GST-ETS1 WT.
Expression vectors of WT and various deletion mutants of murine GFI1 were constructed as reported previously (Osawa et al., 2002) . Full length of murine GFI1 cDNA and its various mutants were FLAG-tagged at their N-terminus by subcloning into pDNA3-FLAG-tag expression vector (Stratagene, La Jolla, CA, USA). They were FLAG-tag GFI1 WT (aa 1-435), FLAG-tag GFI1 having the Zn-finger domain only (aa 253-435), and FLAG-tag GFI1 with deletion of the Zn-finger domain fused to the nuclear localization signals of simian virus 40 large T antigen (aa 1-252 ). An expression vector of HA-tag ETS1-GFI1 interaction in the repression of Bax gene expression Y Nakazawa et al GFI1 WT was obtained by subcloning of the murine GFI1 cDNA from FLAG-tag GFI1 WT.
The human Bax promoter was isolated from the genomic DNA of peripheral white blood cells using the following primers; forward (from À285 to À264 nt): 5 0 -GAAGATC TGGGCCACTGCACTGCACTCCAGCCTGG-3 0 (BglII site is underlined), and reverse (from À22 to À1 nt): 5 0 -CGGG ATCCAGCATGCTTCCAGGCAGGACGT-3 0 (BamH1 site is underlined). The PCR products were digested with BglII and BamH1 and subcloned into pGL3 basic vector (Bax promoter WT). Several Bax promoters containing mutations in the EBS (GGAA to AATT) and/or in the GBS (GCTT to TAGC) were obtained from the pGL3-Bax promoter vector (Bax promoter mut EBS, Bax promoter mut GBS and Bax promoter mut E,GBS) using a site-directed mutagenesis kit (Stratagene). All of the cloned PCR products were sequenced and were confirmed to have no additional mutations.
Immunoprecipitation and immunoblotting
Preparation of cell lysates was as described previously (Yamamoto et al., 1999) . Immunoprecipitation and immunoblotting were also performed as described previously (Yamamoto et al., 1999) with minor modification. Briefly, a measure of 500 mg of each cell lysate was immunoprecipitated with 1 mg of anti-human GFI1 antibody (N-20, Santa Cruz) and anti-FLAG-tag antibody (M2, Stratagene). Each sample of the immunoprecipitate was washed in 1 Â PBS four times and separated by a 4-12% Nu-PAGE MOPS system (Invitrogen, Carlsbad, CA, USA), and then transferred onto a polyvinylidine difluoride membrane (Millipore, Bedford, MA, USA) using a semidry blotting system. Immunoblotting was performed using standard procedures with polyclonal anti-human ETS1 antibody (C-20, Santa Cruz; N-20, Santa Cruz), HA-tag (Y-11, Santa Cruz) and an anti-FLAG-tag antibody (M2, Stratagene), and visualized using enhanced chemoluminescence ECL-PLUS (GE healthcare).
GST pull-down assay GST fusion proteins were expressed by Escherichia coli BL21 and were purified following the manufacturer's instructions (GE healthcare). Ten milligrams of GST or GST fusion proteins were immobilized to glutathione sepharose beads (GE healthcare). After extensively washing the beads with binding buffer (10 mM Tris-HCl pH 7.4, 1 mM ethylenediaminetetraacetic acid (EDTA), 150 mM NaCl, 1% Triton X-100, and 0.1 mM sodium vanadate as a proteinase inhibitor), the beads were incubated with cell lysates for 4 h at 41C. The beads were then washed four times with binding buffer and bound proteins were separated in 4-12% Nu-PAGE MOPS systems (Invitrogen). The proteins were detected by immunoblot analysis with an anti-FLAG-tag antibody (Stratagene).
Luc assay
Cell extracts for Luc assays were prepared as described previously (Yamamoto et al., 1999) . The reporter plasmids, pTK100-PU x3-Luc, pTK100-PUmut x3-Luc, pTK81-Luc, pTK81-Gfi x4-Luc and an expression vector pCDNA3 GFI1 were also as constructed previously (Yamamoto et al., 1999; Osawa et al., 2002) . The expression vector pEF-ETS1 was also constructed by subcloning of the human ETS1 gene in frame into the pEF expression vector donated by Dr Nagata, Osaka University, Osaka, Japan. Reporter and effector vectors were transfected into 293T cells cultured in 24-well plates. Cell lysates were harvested 48 h after transfection and Luc activity was assayed with 5 ml of cell lysate and 50 ml of pikka gene substrate (Nippongene) using the LB9501 luminometer (Berthold, Badwildbad, Germany).
ChIP assay
ChIP assays were performed as reported previously (Suzuki et al., 2003) . Briefly, adducts crosslinked with chromatin molecules were sheared by sonication until an average length of DNA ladder of 500 bp increments was obtained. Salmon sperm DNA/protein agarose (Upstate Biotech, Temecula, VA, USA) was used instead of the Staph A for immunoprecipitation. Anti-ETS1 and FLAG-tag antibody were employed as described above. Precipitated protein-DNA complexes were washed in low-salt buffer (20 mM TrisHCl pH 8.1, 2 mM EDTA, 150 mM NaCl, 0.1% sodium dodecyl sulfate and 1% Triton X-100), LiCl buffer (10 mM Tris-HCl pH 8.1, 1 mM EDTA, 250 mM LiCl, 1% NP40 and 1% DOC) and 1 Â TE (10 mM Tris-HCl pH8.1, 1 mM EDTA) buffer twice. The precipitated protein-DNA complexes were dissolved in 1 Â TE buffer and incubated at 651C overnight to reverse crosslinks. After treatment with RNase A and proteinase K, DNA was extracted with phenol/chloroform and precipitated with ethanol. Purified DNA was then subjected to 30 cycles of PCR amplification. Primers for the detection of the human b-actin gene were designed as follows; forward 5 0 -CATCACCATTGGCAATGAGC-3 0 , reverse 5 0 -CA TACTCCTGCTTGCTGATC-3 0 , and for the human Bax gene; forward 5 0 -CAGTGAGACCCTGTCTCAAA-3 0 , reverse 5 0 -GCCAAGCTTACTTAGATCGC-3 0 .
Reverse transcription-PCR Total RNA was prepared by using ISOGEN (Nippongene). cDNA was synthesized using Superscript III (Invitrogen) from 1 mg of total RNA and primed with oligo (dT). The primers used were as follows: human ETS1 gene, forward (from 397 to 414 Transfection of siRNA ETS1 siRNA, GFI1 siRNA (Santa Cruz) and GFP siRNA (Nippongene) were transfected into 293T cells using Lipofectamine 2000 (Invitrogen) and Opti-MEM (Gibco, Carlsbad, CA, USA) according to the manufacturer's instructions. Total RNA was extracted 48 h after transfection to examine expression levels of ETS1 and GFI1 mRNA by RT-PCR.
